1. Home
  2. PBT vs ALT Comparison

PBT vs ALT Comparison

Compare PBT & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBT
  • ALT
  • Stock Information
  • Founded
  • PBT 1980
  • ALT 1997
  • Country
  • PBT United States
  • ALT United States
  • Employees
  • PBT N/A
  • ALT N/A
  • Industry
  • PBT Oil & Gas Production
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • PBT Energy
  • ALT Health Care
  • Exchange
  • PBT Nasdaq
  • ALT Nasdaq
  • Market Cap
  • PBT 475.4M
  • ALT 472.3M
  • IPO Year
  • PBT N/A
  • ALT N/A
  • Fundamental
  • Price
  • PBT $10.29
  • ALT $4.78
  • Analyst Decision
  • PBT
  • ALT Strong Buy
  • Analyst Count
  • PBT 0
  • ALT 8
  • Target Price
  • PBT N/A
  • ALT $21.00
  • AVG Volume (30 Days)
  • PBT 99.0K
  • ALT 3.0M
  • Earning Date
  • PBT 01-01-0001
  • ALT 05-08-2025
  • Dividend Yield
  • PBT 4.70%
  • ALT N/A
  • EPS Growth
  • PBT N/A
  • ALT N/A
  • EPS
  • PBT 0.55
  • ALT N/A
  • Revenue
  • PBT $27,114,144.00
  • ALT $20,000.00
  • Revenue This Year
  • PBT N/A
  • ALT N/A
  • Revenue Next Year
  • PBT N/A
  • ALT N/A
  • P/E Ratio
  • PBT $18.52
  • ALT N/A
  • Revenue Growth
  • PBT N/A
  • ALT N/A
  • 52 Week Low
  • PBT $9.43
  • ALT $4.65
  • 52 Week High
  • PBT $14.26
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • PBT 50.75
  • ALT 33.07
  • Support Level
  • PBT $9.72
  • ALT $5.60
  • Resistance Level
  • PBT $10.51
  • ALT $5.13
  • Average True Range (ATR)
  • PBT 0.34
  • ALT 0.35
  • MACD
  • PBT 0.05
  • ALT -0.07
  • Stochastic Oscillator
  • PBT 72.15
  • ALT 8.61

About PBT Permian Basin Royalty Trust

Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

Share on Social Networks: